Frost & Sullivan: OptiSigns Receives the 2025 North American SMB Digital Signage Product Leadership Recognition for Excellence in Digital Transformation and Customer Engagement
OptiSigns recognized for redefining SMB digital signage through automation, flexibility, and enterprise-class…
Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting
- Data demonstrates ofirnoflast's efficacy in myelodysplastic syndrome (MDS) with robust and…
Spectrum Business Receives Frost & Sullivan’s 2025 North American Competitive Strategy Leadership Recognition for Excellence in Dedicated Internet Access
Spectrum Business Leverages Digital Innovation and Customer-Centric Execution to Drive Strategic Excellence…
George Medicines presents long-term efficacy and safety data for single pill triple combination therapy for hypertension at American Heart Associations Scientific Sessions 2025
London, UK, Boston, MA, 9 November 2025 – George Medicines, a late-stage…
Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at American Heart Association Scientific Sessions 2025
November 09, 2025 09:00 ET | Source: Medera Inc. BOSTON, Nov. 09,…
Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025
THE WOODLANDS, Texas, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc.…
Data for Lorundrostat in Chronic Kidney Disease and Hypertension Presented at American Society of Nephrology (ASN) Kidney Week 2025
– Late-breaking presentation of Explore-CKD trial at ASN Kidney Week – –…
e-Contact Receives Frost & Sullivan’s 2025 Latin American Contact Center Solutions Customer Value Leadership Recognition for Excellence in Innovation and Customer Engagement
e-Contact is honored for delivering cost-effective, AI-driven solutions that empower clients and…
Andor Health’s Agentic AI Platform, ThinkAndor, Receives Frost & Sullivan’s 2025 North American Transformational Innovation Leadership Recognition for Excellence in Acute Care Virtual Health
Recognized for its transformational innovation and customer impact in driving the evolution…
Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
November 03, 2025 16:45 ET | Source: Fulcrum Therapeutics, Inc. ― Pociredir…
